4.6 Article

A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients

期刊

EUROPEAN RESPIRATORY JOURNAL
卷 57, 期 6, 页码 -

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/13993003.03103-2020

关键词

-

资金

  1. GlaxoSmithKline RD [NCT03380429]

向作者/读者索取更多资源

This study evaluated the effect of a connected inhaler system on adherence to asthma maintenance therapy, finding that feedback data and increasing patients' use of maintenance medication can improve adherence and reduce the use of rescue medication in patients with uncontrolled asthma.
Suboptimal adherence to maintenance therapy contributes to poor asthma control and exacerbations. This study evaluated the effect of different elements of a connected inhaler system (CIS), comprising clip-on inhaler sensors, a patient-facing app and a healthcare professional (HCP) dashboard, on adherence to asthma maintenance therapy. This was an open-label, parallel-group, 6-month, randomised controlled trial in adults with uncontrolled asthma (asthma control test (ACT) score less than 20) on fixed-dose inhaled corticosteroids/ long-acting beta-agonist maintenance therapy (n=437). All subjects received fluticasone furoate/vilanterol ELLIPTA dry-powder inhalers for maintenance and salbutamol/albuterol metered-dose inhalers for rescue, with a sensor attached to each inhaler. Participants were randomised to one of five CIS study arms (allocation ratio 1:1:1:1:1) reflecting the recipient of the data feedback from the sensors, as follows: 1) maintenance use to participants and HCPs (n=87); 2) maintenance use to participants (n=88); 3) maintenance and rescue use to participants and HCPs (n=88); 4) maintenance and rescue use to participants (n=88); and 5) no feedback (control) (n=86). For the primary endpoint, observed mean +/- SD adherence to maintenance therapy over months 4 +/- 6 was 82.2 +/- 16.58% (n=83) in the maintenance to participants and HCPs arm and 70.8 +/- 27.30% (n=85) in the control arm. The adjusted least squares mean +/- SE was 80.9 +/- 3.19% and 69.0 +/- 3.19%, respectively (study arm difference: 12.0%, 95% CI 5.2 +/- 18.8%; p<0.001). Adherence was also significantly greater in the other CIS arms versus the control arm. The mean percentage of rescue medication free days (months 4 +/- 6) was significantly greater in participants receiving data on their rescue use compared with controls. ACT scores improved in all study arms with no significant differences between groups. A CIS can improve adherence to maintenance medication and reduce rescue medication use in patients with uncontrolled asthma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据